West Pharma (NYSE: WST) reported Q3 EPS of $0.44, versus $0.44 reported last year. Revenue for the quarter came in at $344.5 million, versus $355.9 million reported last year.

West Pharma sees FY2015 EPS of $1.79-$1.84.

For earnings history and earnings-related data on West Pharma (WST) click here.